We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

104 hedge funds and large institutions have $964M invested in Heron Therapeutics in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,020% more call options, than puts

Call options by funds: $23.5M | Put options by funds: $1.11M

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

4% more funds holding

Funds holding: 100 → 104 (+4)

4.11% less ownership

Funds ownership: 133.75% → 129.64% (-4.1%)

10% less capital invested

Capital invested by funds: $1.07B → $964M (-$111M)

Holders
104
Holders Change
+4
Holders Change %
+4%
% of All Funds
2.59%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
16
Increased
47
Reduced
25
Closed
11
Calls
$23.5M
Puts
$1.11M
Net Calls
+$22.4M
Net Calls Change
+$22.8M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$81.7M
2
Citigroup
Citigroup
New York
+$15M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.26M
4
TCP
Tourbillon Capital Partners
New York
+$6.37M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.21M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$33.6M
2
CAM
Cormorant Asset Management
Massachusetts
-$9.12M
3
PHS
PFM Health Sciences
California
-$8.52M
4
BC
Broadfin Capital
New York
-$7.66M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$5.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACH
26
ArrowMark Colorado Holdings
Colorado
$7.62M +$431K +29,791 +6%
Goldman Sachs
27
Goldman Sachs
New York
$5.79M +$2.88M +198,562 +90%
PAM
28
Panagora Asset Management
Massachusetts
$5.49M -$665K -45,919 -10%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$5.35M +$391K +26,986 +8%
FLAM
30
First Light Asset Management
Minnesota
$5.09M +$53.6K +3,701 +1%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.84M +$204K +14,086 +7%
LOAMU
32
Lombard Odier Asset Management (USA)
New York
$2.42M – – –
Charles Schwab
33
Charles Schwab
California
$2.36M +$14.9K +1,026 +0.6%
Millennium Management
34
Millennium Management
New York
$2.34M +$2.44M +168,777 New
TCIM
35
TIAA CREF Investment Management
New York
$1.69M +$262K +18,105 +17%
GC
36
Guggenheim Capital
Illinois
$1.62M +$73.5K +5,075 +5%
Allianz Asset Management
37
Allianz Asset Management
Germany
$1.52M +$238K +16,429 +18%
Morgan Stanley
38
Morgan Stanley
New York
$1.4M +$15.1K +1,040 +1%
CS
39
Credit Suisse
Switzerland
$1.38M -$642K -44,317 -31%
Mirae Asset Global Investments
40
Mirae Asset Global Investments
South Korea
$1.28M +$338K +23,361 +34%
TA
41
Teachers Advisors
New York
$1.15M +$191K +13,212 +19%
BGIM
42
Brandywine Global Investment Management
Pennsylvania
$1.12M -$159K -11,010 -12%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.11M -$29K -2,000 -2%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.09M +$85.5K +5,900 +8%
ACM
45
Atika Capital Management
New York
$1.08M -$246K -17,000 -18%
Bank of America
46
Bank of America
North Carolina
$1.06M +$319K +22,036 +41%
BCM
47
BlueCrest Capital Management
Jersey
$948K +$991K +68,434 New
AllianceBernstein
48
AllianceBernstein
Tennessee
$911K +$146K +10,100 +18%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$827K – – –
GH
50
GAM Holding
Switzerland
$819K – – –
1
2
3 4 5

HRTX Hedge Fund Activity: Q2 2017 in Review

104 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2017, worth a combined $964M — down 10% from $1.07B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new HRTX positions and 11 closed out — a net gain of 5 holders — while 47 added to existing stakes and 25 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $81.7M. The largest seller was Invesco, cutting an estimated $33.6M.

  • 104 institutional investors held Heron Therapeutics (HRTX) as of Q2 2017, up from 100 in Q1 2017.
  • Funds reported $964M of Heron Therapeutics stock for Q2 2017, down 10% quarter-over-quarter.
  • 16 funds opened new Heron Therapeutics positions in Q2 2017 and 11 closed out, a net change of +5 holders.
  • The largest Heron Therapeutics buyer in Q2 2017 was Janus Henderson Group, an estimated $81.7M added.
  • The largest Heron Therapeutics seller in Q2 2017 was Invesco, an estimated $33.6M sold.

Based on aggregated 13F filings for Q2 2017.